Dr. Hamish Cameron has been appointed as a director and CEO of CAT Limited.
Paul D. Rubin, M.D. has stepped down from his position as president, CEO and director of Critical Therapeutics. The company's board has appointed Robert Zeiger to serve as executive chairman.
The NeoStrata Company has named Mark D. Steele CEO.
Justin Leushner has been named president of Pheromone Sciences.
Radiant Research has selected Pamela M. Spaniac as president.
Poniard Pharmaceuticals announced that CFO Susan Berland will be leaving the company to pursue other opportunities. Caroline Loewy, executive vice president, strategic planning and investor relations, will assume the role of CFO.
Gregory J. Davenport, Ph.D., has joined Gwathmey as executive vice president.
Dennis Rossi, senior vice president and general manager of Gene Logic's genomics division, has announced his resignation.
Exilixis has named Gisela M. Schwab, M.D., senior vice president and chief medical officer.
InfaCare Pharmaceutical has appointed Simon Tulloch, M.D. as chief medical officer.
Avidia has named Paulette A. Dillon senior vice president and chief business officer and Charles Sholtz, Ph.D., J.D., vice president of intellectual property and legal affairs.
Ligand Pharmaceuticals has announced that Matthew T. Witte has been promoted to the position of senior vice president, marketing and sales.
Celator Pharmaceuticals has named pharmaceutical industry veteran Felix Botelho as head of commercial development.
Cipher Pharmaceuticals has appointed Dr. Jason A. Gross as vice president, scientific affairs.
Poniard Pharmaceuticals has named Ronald A. Martell, senior vice president of commercial operations at ImClone Systems Incorporated, to its board of directors.
Xenome Limited today announced the establishment of a scientific advisory board with the appointment of Richard DiMarchi, John Wood and Alan Robertson.
Alnylam Pharmaceuticals has elected Judy Lieberman, M.D., Ph.D., to its scientific advisory board.